Consider This Before Taking a Position in Monster Beverage (MNST)

More and more people are talking about Monster Beverage over the last few weeks. Is it worth buying the Beverages stock at a price of $55.88? Only time will tell. The information below will give you a basic idea of what this investment may entail:

  • Monster Beverage has moved 13.1% over the last year, and the S&P 500 logged a change of 28.5%

  • MNST has an average analyst rating of buy and is -11.88% away from its mean target price of $63.41 per share

  • Its trailing earnings per share (EPS) is $1.48

  • Monster Beverage has a trailing 12 month Price to Earnings (P/E) ratio of 37.8 while the S&P 500 average is 15.97

  • Its forward earnings per share (EPS) is $1.82 and its forward P/E ratio is 30.7

  • The company has a Price to Book (P/B) ratio of 7.38 in contrast to the S&P 500's average ratio of 2.95

  • Monster Beverage is part of the Consumer Staples sector, which has an average P/E ratio of 21.21 and an average P/B of 4.12

  • MNST has reported YOY quarterly earnings growth of 43.3% and gross profit margins of 0.5%

  • The company has a free cash flow of $941.28 Million, which refers to the total sum of all its inflows and outflows of cash over the last quarter

  • Monster Beverage Corporation, through its subsidiaries, engages in development, marketing, sale, and distribution of energy drink beverages and concentrates in the United States and internationally. The company operates through three segments: Finished Product, Concentrate, and Other.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.